Gil Horsky The Marker on GLP-1 and Foodtech – What Comes After Appetite Reduction

The Marker Logo

GLP-1 medications are changing the conversation around appetite, weight management and metabolic health. But according to Gil Horsky, reducing appetite does not reduce the importance of nutrition. In many cases, it makes food quality even more important. In a recent TheMarker article, Gil Horsky explains that when people eat smaller amounts, protein, fibre, vitamins and […]

Horsky to ynet: “The future is food as medicine, bridging pharma and nutrition”

In a fascinating conversation featured on ynet, Gil Horsky shared his vision for the future of global nutrition. Horsky, who previously founded the corporate venture capital arm of the snacking giant Mondelēz, identifies the emergence of an entirely new category within the industry—one that bridges the gap between the food and pharmaceutical worlds. “I believe […]

“We are at a historic turning point in the food industry”

Speaking with Calcalist, Gil Horsky breaks down the tectonic shifts currently reshaping the global food industry in the wake of the GLP-1 weight loss drug boom. As the Chairman and Co-founder of Lembas, Horsky argues that we have reached a “historic turning point” where our food is becoming more intelligent and science-driven than ever before. […]